Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
about
Skeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsIs REDD1 a Metabolic Éminence Grise?Reversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic miceInsulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human AstrocytesAltered nutrient response of mTORC1 as a result of changes in REDD1 expression: effect of obesity vs. REDD1 deficiency.Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic ratsRegulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in adipocytes.MST1, a key player, in enhancing fast skeletal muscle atrophy.A soluble activin receptor type IIB does not improve blood glucose in streptozotocin-treated miceRNA sequencing identifies upregulated kyphoscoliosis peptidase and phosphatidic acid signaling pathways in muscle hypertrophy generated by transgenic expression of myostatin propeptideRole of IGF-I in follistatin-induced skeletal muscle hypertrophy.Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle.Cellular and tissue expression of DAPIT, a phylogenetically conserved peptide.Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism.Myostatin inhibition therapy for insulin-deficient type 1 diabetesGadd45a Protein Promotes Skeletal Muscle Atrophy by Forming a Complex with the Protein Kinase MEKK4Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.Myostatin induces DNA damage in skeletal muscle of streptozotocin-induced type 1 diabetic mice.Overlapped metabolic and therapeutic links between Alzheimer and diabetes.Activation of mTOR: a culprit of Alzheimer's disease?Cacna1c in the Prefrontal Cortex Regulates Depression-Related Behaviors via REDD1.Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).Cardiac and vascular atrogin-1 mRNA expression is not associated with dexamethasone efficacy in the monocrotaline model of pulmonary hypertension.Investigation into Hypoglycemic, Antihyperlipidemic, and Renoprotective Potentials of Dennettia tripetala (Pepper Fruit) Seed in a Rat Model of Diabetes.Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins.Morphological, molecular and hormonal adaptations to early morning versus afternoon resistance training.Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening.Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
P2860
Q26775403-991620C7-96A2-47B2-98B5-A06B81363DB5Q28075486-F9D34A7F-16DC-40FC-AF83-C31652D6B61EQ28540078-4F07F052-4169-40DD-BF80-244B30FE1F83Q33887259-B7DF2C5F-0477-4860-B9E0-E09404BC7E75Q34006278-7FD50C0D-788B-4CCA-ADDB-109E949E67D3Q34173547-5750CBE2-E0F6-493A-A48A-9889E1B6B999Q34526040-3B78BB04-2788-4BE3-B365-32010CACBA75Q34572209-0E32CB3B-DE65-4D67-BFB3-3DB32F8B5A6FQ34785536-68320834-B81A-4626-BCE0-206A8855A721Q35585587-831C2165-E6B3-4D3E-99A9-B6C38124BD77Q36066585-559785AF-F88E-486C-BC39-5D83800BE991Q36123395-583C2DE0-13E8-4243-99BF-2612155E82DEQ36193611-7746E0FB-C41B-4539-AF59-EC4A88E499D0Q37139408-4F686F80-E06F-4999-843A-E3102E02BABCQ37223399-593CE4C9-B399-4F12-8408-A454BD63D203Q37242442-74302798-9C0D-4235-ABF2-F0DB18F2F774Q37282125-97EF45CC-08C2-4A77-A8A7-448A358A47F8Q37608483-EA832233-24DA-4063-AE95-D3CD136717C8Q38046539-0A283FDE-0FBB-425B-8D52-6BAC6D803F33Q38443497-7FBCD389-122F-4F83-82A3-707A71E161E8Q40439261-119119F0-1BA1-47A6-916E-CF576EC5F4A1Q40728869-8A30EC9E-A6D5-49EF-82D1-364445D88F7EQ42250061-5B37B6B4-F00D-41ED-B0D9-E8B623CBEEE7Q46145836-077F850F-E518-4199-AD27-3B9C48FB4394Q46401273-E3CDAFC9-DBBC-41E4-8904-54A15206DEF3Q47240111-DE59D841-656A-41DA-A454-88811270B1C0Q50061735-D49CB6FE-FB6F-42B8-AC20-7269A98E575AQ50973442-0957AD26-AF74-4993-9BD0-7B126DCB9B32
P2860
Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@en
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@nl
type
label
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@en
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@nl
prefLabel
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@en
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@nl
P2860
P50
P1476
Altered REDD1, myostatin, and ...... duced diabetic muscle atrophy.
@en
P2860
P304
P356
10.1152/AJPENDO.00398.2011
P577
2011-11-08T00:00:00Z